MedicinePathologyPharmacologyImmunopathologyImmunopharmacologyImmunotoxicologyHepatic ToxicityHepatotoxicity MechanismsLiver DiseaseLymphoid Organ ToxicityVeterinary Drug HepatotoxicityGranulomatous HepatitisGranulomatous LesionsHepatic Function TestsHypochromic Microcytic AnemiaImmunosuppressive Drug ToxicityImpaired Kidney FunctionInflammation In Lymphoid OrgansPathological Science
In rats given an immunotherapeutic dose (25 mg/kg orally each day for 7 weeks) of cyclosporin A (Cy A) characteristic drug-induced pathological changes were observed, including impaired liver function, renal proximal tubular cell damage, progressive lymphopenia, lymphocyte depletion in lymphoid organs and marrow hypoplasia. Several additional and previously unreported features of Cy A toxicity were also demonstrated. The changes in renal and hepatic function were biphasic with temporary improvement during the course of the study. The most striking liver damage was in the form of a granulomatous hepatitis and a hypochromic microcytic anaemia developed in all experimental animals.
14
Toxicity of the immune suppressant cyclosporin A in the rat
Jane T. Blair, Angus W. Thomson, P. H. Whiting et al. · The Journal of Pathology · 1982 · 116 citations
Medicine, Pharmacology, Toxicology +17
Nature of the toxicity of cyclosporin A in the rat
Michael J.G. Farthing, Michael Clark, Ann Pendry et al. · Biochemical Pharmacology · 1981 · 104 citations
Pharmacy, Pharmacology, Toxicology +10
Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines.
Angus W. Thomson, D K Moon, Carolyn L. Geczy et al. · PubMed · 1983 · 102 citations
Experimental cyclosporin A nephrotoxicity.
P. H. Whiting, Angus W. Thomson, Jane T. Blair et al. · PubMed · 1982 · 96 citations · Full text
Medicine, Nephrology, Pharmacology +17